Twist Bioscience Corp

23. Sept. 2026, 20:07 UTC

Twist Bioscience Corp shares fell sharply on Wednesday, closing significantly lower after a brief recovery, marking three consecutive sessions of declines.

22. Sept. 2026, 23:05 UTC

Twist Bioscience Corp remained roughly flat in after-market trading, fluctuating around unchanged while significantly above its 20-day moving average.

21. Sept. 2026, 23:06 UTC

Twist Bioscience shares are trading modestly lower in after-market hours following CEO Emily M. Leproust's $55.40 million stock sale on September 17.

18. Sept. 2026, 20:03 UTC

Twist Bioscience Corp's stock is rising after a partnership with Eli Lilly’s TuneLab and Leerink raised its price target to $160 from $120.

17. Sept. 2026, 23:06 UTC

Twist Bioscience Corp's stock rises after a partnership with Eli Lilly's TuneLab, with Leerink raising its price target to $160 and increased fiscal 2026 sales guidance.

16. Sept. 2026, 23:01 UTC

Twist Bioscience Corp's shares have declined in after-market trading, reaching their lowest level since Wednesday's close despite previous upward momentum.

15. Sept. 2026, 23:02 UTC

Twist Bioscience Corp shares are lower in after-market hours following a significant decline in the New York Empire State Manufacturing Index, which missed expectations.

14. Sept. 2026, 20:07 UTC

Twist Bioscience Corp is higher during Monday's session, recovering from earlier losses. No specific news was identified to explain the price movement.

11. Sept. 2026, 20:08 UTC

Twist Bioscience shares are higher after being identified for bullish potential, supported by a MACD pinch technical indicator. The stock advanced despite earlier session dips.

10. Sept. 2026, 23:01 UTC

Twist Bioscience Corp shares are trading higher in after-market hours. No specific news was identified to explain the movement.

9. Sept. 2026, 20:07 UTC

Twist Bioscience shares are lower as BWS Financial initiates coverage with a Sell rating, contrasting UBS's Neutral rating and higher price target of $144.00.

8. Sept. 2026, 20:07 UTC

Twist Bioscience Corp shares are higher, driven by increased recognition of AI applications in healthcare and a "Moderate Buy" consensus rating from brokerages.

3. Sept. 2026, 19:36 UTC

Twist Bioscience reported $118.4 million in Q3 revenue and raised its guidance, yet shares are lower, continuing a five-session decline.

2. Sept. 2026, 23:06 UTC

Twist Bioscience Corp. shares are lower in after-market hours, extending a trend of five consecutive daily declines. Earlier, the stock briefly rose before falling again.

1. Sept. 2026, 19:56 UTC

Twist Bioscience Corp shares are lower amid broader market pressures and rising Treasury yields. The Russell 2000 Index also declined during Tuesday's session.

31. Aug. 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading, following no specific news. The stock remains above its 20-day moving average.

28. Aug. 2026, 22:51 UTC

Twist Bioscience shares are higher in after-market trading. Rising Treasury yields may be influencing investor sentiment in the biotechnology sector.

27. Aug. 2026, 23:02 UTC

Twist Bioscience shares are higher in after-market hours, recovering from earlier losses. Jobless claims data suggests strength in the labor market.

26. Aug. 2026, 19:36 UTC

Twist Bioscience Corp shares are trading higher today, maintaining a position near the upper end of their one-month range. No specific news has been identified.

25. Aug. 2026, 23:06 UTC

Twist Bioscience Corp shares are higher in after-market hours, rebounding from a post-close low amid broader market support from falling crude oil prices and treasury yields.

24. Aug. 2026, 23:51 UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining gains from earlier in the session and staying above key moving averages.

21. Aug. 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading, despite remaining well above their 20-day moving average and last month's price levels.

20. Aug. 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading. Broader market pressures, including rising crude oil prices and geopolitical tensions, may be influencing sentiment.

19. Aug. 2026, 23:06 UTC

Twist Bioscience Corp shares are lower in after-market hours following a critical short report from Scorpion Capital questioning the company's AI-driven protein design strategy.

18. Aug. 2026, 23:21 UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining an upward trend and positioned above its 20-day moving average.

17. Aug. 2026, 22:36 UTC

Twist Bioscience Corp shares are slightly higher in after-market hours, maintaining strong performance above their 20-day moving average despite earlier declines.

14. Aug. 2026, 19:06 UTC

Twist Bioscience shares are lower today, continuing a decline since Thursday amid broader market volatility and recent U.S. retail sales data.

13. Aug. 2026, 23:06 UTC

Twist Bioscience Corp shares are lower in after-market trading, influenced by broader market declines and recent macroeconomic data on jobless claims and producer prices.

12. Aug. 2026, 19:16 UTC

Twist Bioscience Corp is higher Wednesday, tracking broader U.S. stock gains amid strength in AI sectors following positive quarterly results from CoreWeave and Super Micro Computer.

11. Aug. 2026, 23:46 UTC

Twist Bioscience Corp shares declined during after-market hours, following a drop in the Russell 2000 Index amid investor caution ahead of the consumer price index report.